Selected research
Industry Research
Functional Genomics Industry Research Report 2026
Market perspective
The global Functional Genomics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Functional Genomics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Functional Genomics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Functional Genomics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Functional Genomics include Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories, Inc., (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, Hoffmann-La Roche Ltd, Illumina, Inc., Merck KGaA and MRM Proteomics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Functional Genomics market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Functional Genomics.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Functional Genomics Market by Company
Agilent Technologies, Inc.
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
(Integrated DNA Technologies, Inc.)
Exact Sciences Corporation
Hoffmann-La Roche Ltd
Illumina, Inc.
Merck KGaA
MRM Proteomics
Pacific Biosciences of California, Inc.
Promega Corporation
QIAGEN
Thermo Fisher Scientific Inc.
Functional Genomics Segment by Type
Kits & Assays
Instruments
Assays
Functional Genomics Segment by Application
Transcriptomics
Epigenomics
Proteomics
Metabolomics
Functional Genomics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Functional Genomics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Functional Genomics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Functional Genomics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Functional Genomics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Kits & Assays
- Instruments
- Assays
Applications
- Transcriptomics
- Epigenomics
- Proteomics
- Metabolomics
Companies covered
- Agilent Technologies, Inc.
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- (Integrated DNA Technologies, Inc.)
- Exact Sciences Corporation
- Hoffmann-La Roche Ltd
- Illumina, Inc.
- Merck KGaA
- MRM Proteomics
- Pacific Biosciences of California, Inc.
- Promega Corporation
- QIAGEN
- Thermo Fisher Scientific Inc.
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Functional Genomics by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Kits & Assays
- 2.2.3 Instruments
- 2.2.4 Assays
- 2.3 Functional Genomics by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Transcriptomics
- 2.3.3 Epigenomics
- 2.3.4 Proteomics
- 2.3.5 Metabolomics
- 2.4 Assumptions and Limitations
3 Functional Genomics Breakdown Data by Type
- 3.1 Global Functional Genomics Historic Market Size by Type (2021-2026)
- 3.2 Global Functional Genomics Forecasted Market Size by Type (2027-2032)
4 Functional Genomics Breakdown Data by Application
- 4.1 Global Functional Genomics Historic Market Size by Application (2021-2026)
- 4.2 Global Functional Genomics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Functional Genomics Market Perspective (2021-2032)
- 5.2 Global Functional Genomics Growth Trends by Region
- 5.2.1 Global Functional Genomics Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Functional Genomics Historic Market Size by Region (2021-2026)
- 5.2.3 Functional Genomics Forecasted Market Size by Region (2027-2032)
- 5.3 Functional Genomics Market Dynamics
- 5.3.1 Functional Genomics Industry Trends
- 5.3.2 Functional Genomics Market Drivers
- 5.3.3 Functional Genomics Market Challenges
- 5.3.4 Functional Genomics Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Functional Genomics Players by Revenue
- 6.1.1 Global Top Functional Genomics Players by Revenue (2021-2026)
- 6.1.2 Global Functional Genomics Revenue Market Share by Players (2021-2026)
- 6.2 Global Functional Genomics Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Functional Genomics Head Office and Area Served
- 6.4 Global Functional Genomics Players, Product Type & Application
- 6.5 Global Functional Genomics Manufacturers Established Date
- 6.6 Global Functional Genomics Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Functional Genomics Market Size (2021-2032)
- 7.2 North America Functional Genomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Functional Genomics Market Size by Country (2021-2026)
- 7.4 North America Functional Genomics Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Functional Genomics Market Size (2021-2032)
- 8.2 Europe Functional Genomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Functional Genomics Market Size by Country (2021-2026)
- 8.4 Europe Functional Genomics Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Functional Genomics Market Size (2021-2032)
- 9.2 Asia-Pacific Functional Genomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Functional Genomics Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Functional Genomics Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Functional Genomics Market Size (2021-2032)
- 10.2 South America Functional Genomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Functional Genomics Market Size by Country (2021-2026)
- 10.4 South America Functional Genomics Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Functional Genomics Market Size (2021-2032)
- 11.2 Middle East & Africa Functional Genomics Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Functional Genomics Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Functional Genomics Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Agilent Technologies, Inc.
- 12.1.1 Agilent Technologies, Inc. Company Information
- 12.1.2 Agilent Technologies, Inc. Business Overview
- 12.1.3 Agilent Technologies, Inc. Revenue in Functional Genomics Business (2021-2026)
- 12.1.4 Agilent Technologies, Inc. Functional Genomics Product Portfolio
- 12.1.5 Agilent Technologies, Inc. Recent Developments
- 12.2 Becton, Dickinson and Company (BD)
- 12.2.1 Becton, Dickinson and Company (BD) Company Information
- 12.2.2 Becton, Dickinson and Company (BD) Business Overview
- 12.2.3 Becton, Dickinson and Company (BD) Revenue in Functional Genomics Business (2021-2026)
- 12.2.4 Becton, Dickinson and Company (BD) Functional Genomics Product Portfolio
- 12.2.5 Becton, Dickinson and Company (BD) Recent Developments
- 12.3 Bio-Rad Laboratories, Inc.
- 12.3.1 Bio-Rad Laboratories, Inc. Company Information
- 12.3.2 Bio-Rad Laboratories, Inc. Business Overview
- 12.3.3 Bio-Rad Laboratories, Inc. Revenue in Functional Genomics Business (2021-2026)
- 12.3.4 Bio-Rad Laboratories, Inc. Functional Genomics Product Portfolio
- 12.3.5 Bio-Rad Laboratories, Inc. Recent Developments
- 12.4 (Integrated DNA Technologies, Inc.)
- 12.4.1 (Integrated DNA Technologies, Inc.) Company Information
- 12.4.2 (Integrated DNA Technologies, Inc.) Business Overview
- 12.4.3 (Integrated DNA Technologies, Inc.) Revenue in Functional Genomics Business (2021-2026)
- 12.4.4 (Integrated DNA Technologies, Inc.) Functional Genomics Product Portfolio
- 12.4.5 (Integrated DNA Technologies, Inc.) Recent Developments
- 12.5 Exact Sciences Corporation
- 12.5.1 Exact Sciences Corporation Company Information
- 12.5.2 Exact Sciences Corporation Business Overview
- 12.5.3 Exact Sciences Corporation Revenue in Functional Genomics Business (2021-2026)
- 12.5.4 Exact Sciences Corporation Functional Genomics Product Portfolio
- 12.5.5 Exact Sciences Corporation Recent Developments
- 12.6 Hoffmann-La Roche Ltd
- 12.6.1 Hoffmann-La Roche Ltd Company Information
- 12.6.2 Hoffmann-La Roche Ltd Business Overview
- 12.6.3 Hoffmann-La Roche Ltd Revenue in Functional Genomics Business (2021-2026)
- 12.6.4 Hoffmann-La Roche Ltd Functional Genomics Product Portfolio
- 12.6.5 Hoffmann-La Roche Ltd Recent Developments
- 12.7 Illumina, Inc.
- 12.7.1 Illumina, Inc. Company Information
- 12.7.2 Illumina, Inc. Business Overview
- 12.7.3 Illumina, Inc. Revenue in Functional Genomics Business (2021-2026)
- 12.7.4 Illumina, Inc. Functional Genomics Product Portfolio
- 12.7.5 Illumina, Inc. Recent Developments
- 12.8 Merck KGaA
- 12.8.1 Merck KGaA Company Information
- 12.8.2 Merck KGaA Business Overview
- 12.8.3 Merck KGaA Revenue in Functional Genomics Business (2021-2026)
- 12.8.4 Merck KGaA Functional Genomics Product Portfolio
- 12.8.5 Merck KGaA Recent Developments
- 12.9 MRM Proteomics
- 12.9.1 MRM Proteomics Company Information
- 12.9.2 MRM Proteomics Business Overview
- 12.9.3 MRM Proteomics Revenue in Functional Genomics Business (2021-2026)
- 12.9.4 MRM Proteomics Functional Genomics Product Portfolio
- 12.9.5 MRM Proteomics Recent Developments
- 12.10 Pacific Biosciences of California, Inc.
- 12.10.1 Pacific Biosciences of California, Inc. Company Information
- 12.10.2 Pacific Biosciences of California, Inc. Business Overview
- 12.10.3 Pacific Biosciences of California, Inc. Revenue in Functional Genomics Business (2021-2026)
- 12.10.4 Pacific Biosciences of California, Inc. Functional Genomics Product Portfolio
- 12.10.5 Pacific Biosciences of California, Inc. Recent Developments
- 12.11 Promega Corporation
- 12.11.1 Promega Corporation Company Information
- 12.11.2 Promega Corporation Business Overview
- 12.11.3 Promega Corporation Revenue in Functional Genomics Business (2021-2026)
- 12.11.4 Promega Corporation Functional Genomics Product Portfolio
- 12.11.5 Promega Corporation Recent Developments
- 12.12 QIAGEN
- 12.12.1 QIAGEN Company Information
- 12.12.2 QIAGEN Business Overview
- 12.12.3 QIAGEN Revenue in Functional Genomics Business (2021-2026)
- 12.12.4 QIAGEN Functional Genomics Product Portfolio
- 12.12.5 QIAGEN Recent Developments
- 12.13 Thermo Fisher Scientific Inc.
- 12.13.1 Thermo Fisher Scientific Inc. Company Information
- 12.13.2 Thermo Fisher Scientific Inc. Business Overview
- 12.13.3 Thermo Fisher Scientific Inc. Revenue in Functional Genomics Business (2021-2026)
- 12.13.4 Thermo Fisher Scientific Inc. Functional Genomics Product Portfolio
- 12.13.5 Thermo Fisher Scientific Inc. Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst